Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

166 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Assessing cardiovascular drug safety for clinical decision-making.
Woosley RL, Romero K. Woosley RL, et al. Nat Rev Cardiol. 2013 Jun;10(6):330-7. doi: 10.1038/nrcardio.2013.57. Epub 2013 Apr 16. Nat Rev Cardiol. 2013. PMID: 23591268 Review.
Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data.
Conrado DJ, Duvvuri S, Geerts H, Burton J, Biesdorf C, Ahamadi M, Macha S, Hather G, Francisco Morales J, Podichetty J, Nicholas T, Stephenson D, Trame M, Romero K, Corrigan B; Drug Development Tools in the Alzheimer Disease Continuum (DDT-AD) Working Group. Conrado DJ, et al. Clin Pharmacol Ther. 2020 Apr;107(4):796-805. doi: 10.1002/cpt.1782. Epub 2020 Mar 11. Clin Pharmacol Ther. 2020. PMID: 31955409 Review.
Medical decision support systems and therapeutics: The role of autopilots.
Woosley RL, Whyte J, Mohamadi A, Romero K. Woosley RL, et al. Clin Pharmacol Ther. 2016 Feb;99(2):161-4. doi: 10.1002/cpt.259. Epub 2015 Oct 22. Clin Pharmacol Ther. 2016. PMID: 26352903
Adverse Drug Event Causality Analysis (ADECA): A Process for Evaluating Evidence and Assigning Drugs to Risk Categories for Sudden Death.
Woosley RL, Romero K, Heise CW, Gallo T, Tate J, Woosley RD, Ward S. Woosley RL, et al. Drug Saf. 2017 Jun;40(6):465-474. doi: 10.1007/s40264-017-0519-0. Drug Saf. 2017. PMID: 28275963 Review.
CredibleMeds.org: What does it offer?
Woosley RL, Black K, Heise CW, Romero K. Woosley RL, et al. Trends Cardiovasc Med. 2018 Feb;28(2):94-99. doi: 10.1016/j.tcm.2017.07.010. Epub 2017 Aug 1. Trends Cardiovasc Med. 2018. PMID: 28801207 Review.
Clarification to the www.qtdrugs.org updated lists.
Romero K, Woosley RL. Romero K, et al. Pharmacoepidemiol Drug Saf. 2009 May;18(5):423-4. doi: 10.1002/pds.1727. Pharmacoepidemiol Drug Saf. 2009. PMID: 19382150 No abstract available.
Time to replace Bazett's QT-correction.
Woosley RL, Romero K. Woosley RL, et al. Pacing Clin Electrophysiol. 2009 Nov;32(11):1379-80. doi: 10.1111/j.1540-8159.2009.02513.x. Epub 2009 Aug 27. Pacing Clin Electrophysiol. 2009. PMID: 19712074 No abstract available.
The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseases.
Romero K, de Mars M, Frank D, Anthony M, Neville J, Kirby L, Smith K, Woosley RL. Romero K, et al. Clin Pharmacol Ther. 2009 Oct;86(4):365-7. doi: 10.1038/clpt.2009.165. Clin Pharmacol Ther. 2009. PMID: 19763117
Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshop.
Romero K, Sinha V, Allerheiligen S, Danhof M, Pinheiro J, Kruhlak N, Wang Y, Wang SJ, Sauer JM, Marier JF, Corrigan B, Rogers J, Lambers Heerspink HJ, Gumbo T, Vis P, Watkins P, Morrison T, Gillespie W, Gordon MF, Stephenson D, Hanna D, Pfister M, Lalonde R, Colatsky T. Romero K, et al. J Pharmacokinet Pharmacodyn. 2014 Dec;41(6):545-52. doi: 10.1007/s10928-014-9390-0. Epub 2014 Oct 7. J Pharmacokinet Pharmacodyn. 2014. PMID: 25288257
166 results
Jump to page
Feedback